Search

Author/Creator Bennett, John M

1. Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial. Issue 11 (November 2021)

Authors:
DiNardo, Courtney D; Schuh, Andre C; Stein, Eytan M; Montesinos, Pau; Wei, Andrew H; de Botton, Stéphane; Zeidan, Amer M; Fathi, Amir T; Kantarjian, Hagop M; Bennett, John M; Frattini, Mark G; Martin-Regueira, Patricia; Lersch, Frederik; Gong, Jing; Hasan, Maroof; Vyas, Paresh; Döhner, Hartmut
Journal:
Lancet oncology
Issue:
Volume 22:Issue 11(2021)
Page Start:
1597
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search